A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Kivu Bioscience Inc.
Kivu Bioscience Inc.
Travera Inc
Bayer
Actuate Therapeutics Inc.
AstraZeneca
Hoffmann-La Roche
ViroMissile, Inc.
Angiex, Inc.
MacroGenics
Adela, Inc
Var2 Pharmaceuticals
Degron Therapeutics Co.
Bristol-Myers Squibb
Actym Therapeutics, Inc.
AVM Biotechnology Inc
Sensei Biotherapeutics, Inc.
Lantheus Medical Imaging
NextPoint Therapeutics, Inc.
OncoC4, Inc.
ADC Therapeutics S.A.
Tempus AI
Elevation Oncology
Labcorp Corporation of America Holdings, Inc
Intensity Therapeutics, Inc.
Cybrexa Therapeutics
Agenus Inc.
Cyteir Therapeutics, Inc.
Taproot Health
Shanghai PerHum Therapeutics Co., Ltd.
Rain Oncology Inc
NantCell, Inc.
Xencor, Inc.
Corvus Pharmaceuticals, Inc.
Sumitomo Pharma America, Inc.
pharmaand GmbH
Hoffmann-La Roche
Kineta Inc.
Tempest Therapeutics
Shanghai Yunying Medical Technology
Shanghai Yunying Medical Technology
Sorrento Therapeutics, Inc.
Quadriga Biosciences, Inc.
Genzada Pharmaceuticals USA, Inc.
MacroGenics
NKGen Biotech, Inc.
SpeciCare
Tocagen Inc.
Shenzhen BinDeBio Ltd.
TG Therapeutics, Inc.
Pfizer